Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma [Phase 4]
Phase 4 trial comparing a single oral dose of dexamethasone to a five-day prednisone regimen in adults with asthma has completed.
-
FDA approval · 2016-01-06FDA Approved: FLUTICASONE PROPIONATE HFA — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Fluticasone Propionate HFA submitted by Prasco Laboratories.
-
CLINICAL_TRIALS research · 2016-01-06Clinical Trial Update: Epidemiology of Pediatric Asthma Hospitalization
Clinical trial update summarizing the epidemiology of pediatric asthma hospitalizations, including patterns and potential risk factors obser…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: To Evaluate the Use of ASTHMA IQ in a Primary Care Setting
A completed clinical trial evaluating the ASTHMA IQ tool for use in primary care to manage asthma.
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: A Pilot Stress Management Intervention Study for High Risk Children With Asthma [NA]
This document reports the completion of a pilot stress management intervention trial for high-risk children with asthma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-01-04FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Montelukast Sodium from Torrent Pharmaceuticals Limited. The entry indicates a supplemental appr…
-
FDA approval · 2016-01-04FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approves a supplemental application for Montelukast Sodium from Torrent Pharmaceuticals Limited under ANDA 201515.
-
CLINICAL_TRIALS withdrawal · 2015-12-29Clinical Trial Update: Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure [Phase 3]
A Phase 3 trial evaluating the Hattler Respiratory Assist Catheter for severe respiratory failure has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Antibiotics in Infancy--Risk Factor for Childhood Asthma
This completed clinical trial evaluates whether antibiotic exposure in infancy is a risk factor for developing asthma in childhood. The stud…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Childhood Asthma Program in NYC Health Department Clinics
A childhood asthma clinical trial conducted in NYC Health Department clinics, led by Columbia University, has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma [Phase 3]
A Phase 3 trial evaluating two doses of tiotropium Respimat versus placebo in children with severe persistent asthma, reporting efficacy and…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge Model [Phase 2]
Phase 2 trial update showing completion of a study evaluating JNJ 40929837 for asthma using a bronchial allergen challenge model.
-
CLINICAL_TRIALS research · 2015-12-21Clinical Trial Update: Evaluation of the Prevalence of Asthma in a Cohort of Children Born After IVF (Aged 11-15) Compared With a Control Group
The document reports an update on a clinical trial assessing the prevalence of asthma in children aged 11-15 born after IVF compared with a …
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma [Phase 2]
This is an update on a Phase 2 dose-ranging study evaluating sublingual immunotherapy tablets containing house dust mite allergen extracts i…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Occupation and Asthma in an Urban Low Income Population
This completed clinical trial from NYU Langone Health investigated the relationship between occupation and asthma in an urban, low-income po…
-
FDA approval · 2015-12-11FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
FDA approved a supplemental application for PROAIR DIGIHALER (albuterol sulfate) from Teva Respiratory, LLC, adding the DigiHALER device var…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils [Phase 2]
Phase 2 dose-ranging pharmacokinetic and pharmacodynamic study of mepolizumab in asthma patients with elevated eosinophils. Results have bee…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial [Phase 4]
Phase 4 clinical trial update in asthma comparing a leukotriene modifier with corticosteroid therapy and corticosteroid-salmeterol. The stud…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Case Management and Environmental Control in Asthma [Phase 3]
A Phase 3 clinical trial evaluating case management and environmental control for asthma has completed.
-
FDA approval · 2015-12-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast sodium from Rising Pharma Holdings, Inc. under an ANDA, marking approval of a supple…
-
CLINICAL_TRIALS research · 2015-12-04Clinical Trial Update: Manual Therapy in Patients With Asthma [NA]
The clinical trial NCT02047370 evaluating manual therapy in asthma patients has been suspended.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Trial of Vitamin D3 Supplementation in Paediatric Asthma [NA]
The pediatric asthma trial evaluating Vitamin D3 (cholecalciferol) supplementation has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: PPAR-gamma: a Novel Therapeutic Target for Asthma? [Phase 4]
A Phase 4 trial exploring PPAR-gamma as a therapeutic target for asthma has been terminated. The update provides no trial results.
-
CLINICAL_TRIALS research · 2015-12-02Clinical Trial Update: Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation [Phase 4]
This ClinicalTrials.gov entry describes a Phase 4 study of nebulized magnesium sulfate as an adjunct to standard therapy for asthma exacerba…
-
FDA approval · 2015-11-30FDA Approved: BUDESONIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Budesonide from Chartwell RX, LLC, authorizing a change to an existing generic product.